FigureĀ 1.
Survival. The 3-year PFS rates for (A) all patients and (B) patients with cHL were 24% and 0%, respectively, and the 3-year OS rates for (C) all patients and (D) patients with cHL were 83% and 71%, respectively. Survival times started on the date of diagnosis of relapsed lymphoma during pregnancy.